Bret Kenwell

Bret Kenwell is a freelance writer for TheStreet. He studied finance at Central Michigan University and seeks out companies that have the ability to generate above-average growth for many years. Ultimately, the goal is for those companies to become dividend paying titans, cementing their spot in one's portfolio with an incredibly low cost basis. Those picks and Bret's blog can be found at FutureBlueChips.com

 

Twitter: @BretKenwell

Recent Articles By The Author

Cisco Does Something That Makes Another Tech Stock a Worthy Buy

Cisco Does Something That Makes Another Tech Stock a Worthy Buy

Rising DRAM prices are hurting Cisco -- but that's a good thing for Micron and Lam Research.

Applied Materials Stock to Rally More Than 40%: Analysts

Applied Materials Stock to Rally More Than 40%: Analysts

Three analysts raised their price target on AMAT stock, the lowest of which implies about 40% upside.

Alibaba Just Delivered on Promise to Become an Online Colossus, Jim Cramer Says

Alibaba Just Delivered on Promise to Become an Online Colossus, Jim Cramer Says

Alibaba crushed earnings and revenue expectations.

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Evercore ISI analyst Josh Schimmer is bullish on biotech.

Jim Cramer -- Here's How to Play Alibaba's Usually Volatile Earnings Report

Jim Cramer -- Here's How to Play Alibaba's Usually Volatile Earnings Report

Alibaba is up 80% on the year.